| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |